Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey - PubMed (original) (raw)
Comparative Study
Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey
R D Myers et al. Alcohol. 1986 Nov-Dec.
Abstract
An opiate receptor antagonist can reduce excessive alcohol drinking in the rat previously given intracerebroventricular (ICV) infusions of a tetrahydroisoquinoline. Recently, it was found that cerebrospinal fluid (CSF) obtained from volunteers or human patients and subsequently injected ICV in macaque monkeys markedly alters the voluntary consumption of ethyl alcohol in certain of these primates. The purpose of the present study was to determine whether an opioid antagonist would affect the pattern of alcohol intake in selected monkeys which drank excessive amounts of alcohol. Initially, the preferred concentration of alcohol was determined individually for each monkey which consistently drank from 3.0-6.0 g/kg alcohol per day. Subsequently, the single concentration, which ranged from 5-15%, was offered together with water during three consecutive periods as follows: (1) 4-day control baseline period; (2) a 3-day interval during which a saline control vehicle or 0.6 or 1.2 mg/kg naltrexone was administered subcutaneously at 0900 and 1700 hours; and (3) a final 4-day post-injection period during which the alcohol-water preference test was continued. The results showed that both doses of naltrexone significantly attenuated voluntary alcohol drinking up to 60% of the baseline intake during the 3 days of its administration. In two monkeys, alcohol drinking continued to be suppressed up to 50% of basal intake during all or a part of the 4-day post-naltrexone interval. These findings suggest that an opiate receptor mechanism in the brain could be partially involved in the action of the chemical constituents of the human's CSF which serve to induce an abnormally high intake of alcohol in the infra-human primate.
Similar articles
- Buspirone attenuates volitional alcohol intake in the chronically drinking monkey.
Collins DM, Myers RD. Collins DM, et al. Alcohol. 1987 Jan-Feb;4(1):49-56. doi: 10.1016/0741-8329(87)90060-7. Alcohol. 1987. PMID: 3828064 - Attenuation of alcohol drinking in tetrahydroisoquinoline-treated rats by morphine and naltrexone.
Critcher EC, Lin CI, Patel J, Myers RD. Critcher EC, et al. Pharmacol Biochem Behav. 1983 Feb;18(2):225-9. doi: 10.1016/0091-3057(83)90367-2. Pharmacol Biochem Behav. 1983. PMID: 6835979 - Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys.
Kornet M, Goosen C, Van Ree JM. Kornet M, et al. Psychopharmacology (Berl). 1991;104(3):367-76. doi: 10.1007/BF02246038. Psychopharmacology (Berl). 1991. PMID: 1924644 - Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
Myers RD, Lankford MF. Myers RD, et al. Neuropsychopharmacology. 1996 Feb;14(2):139-49. doi: 10.1016/0893-133X(95)00081-N. Neuropsychopharmacology. 1996. PMID: 8822536 - Neuropeptides and alcohol addiction in monkeys.
van Ree JM, Kornet M, Goosen C. van Ree JM, et al. EXS. 1994;71:165-74. doi: 10.1007/978-3-0348-7330-7_17. EXS. 1994. PMID: 8032147 Review.
Cited by
- Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats.
Dhaher R, Toalston JE, Hauser SR, Bell RL, McKinzie DL, McBride WJ, Rodd ZA. Dhaher R, et al. Alcohol. 2012 Feb;46(1):17-27. doi: 10.1016/j.alcohol.2011.08.011. Epub 2011 Oct 1. Alcohol. 2012. PMID: 21962974 Free PMC article. - Motor stimulant effects of ethanol and acetaldehyde injected into the posterior ventral tegmental area of rats: role of opioid receptors.
Sánchez-Catalán MJ, Hipólito L, Zornoza T, Polache A, Granero L. Sánchez-Catalán MJ, et al. Psychopharmacology (Berl). 2009 Jul;204(4):641-53. doi: 10.1007/s00213-009-1495-6. Epub 2009 Feb 24. Psychopharmacology (Berl). 2009. PMID: 19238363 - Isoquinolines, beta-carbolines and alcohol drinking: involvement of opioid and dopaminergic mechanisms.
Myers RD. Myers RD. Experientia. 1989 May 15;45(5):436-43. doi: 10.1007/BF01952025. Experientia. 1989. PMID: 2656285 Review. - Influence of the endogenous opioid system on high alcohol consumption and genetic predisposition to alcoholism.
Gianoulakis C. Gianoulakis C. J Psychiatry Neurosci. 2001 Sep;26(4):304-18. J Psychiatry Neurosci. 2001. PMID: 11590970 Free PMC article. Review. - Opioid pharmacogenetics of alcohol addiction.
Berrettini W. Berrettini W. Cold Spring Harb Perspect Med. 2013 Jul 1;3(7):a012203. doi: 10.1101/cshperspect.a012203. Cold Spring Harb Perspect Med. 2013. PMID: 23729643 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical